EphrinBs/EphBs signaling is involved in modulation of spinal nociceptive processing through a mitogen-activated protein kinases-dependent mechanism.
BACKGROUND
Our previous studies have demonstrated that EphBs receptors and ephrinBs ligands were involved in modulation of spinal nociceptive information. However, the downstream mechanisms that control this process are not well understood. The aim of this study was to further investigate whether mitogen-activated protein kinases (MAPKs), as the downstream effectors, participate in modulation of spinal nociceptive information related to ephrinBs/EphBs.


METHODS
Thermal hyperalgesia and mechanical allodynia were measured using radiant heat and von Frey filaments test. Immunofluorescence staining was used to detect the expression of p-MAPKs and of p-MAPKs/neuronal nuclei, or p-MAPKs/glial fibrillary acidic protein double label. C-Fos expression was determined by immunohistochemistry. The expression of p-MAPKs was also determined by Western blot assay.


RESULTS
Intrathecal injection of ephrinB1-Fc produced a dose- and time-dependent thermal and mechanical hyperalgesia, accompanied by the increase of spinal p-MAPKs and c-Fos expression. Immunofluorescence staining revealed that p-MAPKs colocalized with the neuronal marker (neuronal nuclei) and the astrocyte marker (glial fibrillary acidic protein). Inhibition of MAPKs prevented and reversed pain behaviors and the increase of spinal c-Fos expression induced by intrathecal injection of ephrinB1-Fc. Inhibition of EphBs receptors by intrathecal injection of EphB1-Fc reduced formalin-induced inflammation and chronic constrictive injury-induced neuropathic pain behaviors accompanied by decreased expression of spinal p-MAPKs and c-Fos protein. Furthermore, pretreatment with MK-801, an N-methyl-d-aspartate receptor antagonist, prevented behavioral hyperalgesia and activation of spinal MAPKs induced by intrathecal injection of ephrinB1-Fc.


CONCLUSIONS
These results demonstrated that activation of MAPKs contributed to modulation of spinal nociceptive information related to ephrinBs/EphBs.
Ruan
Jia-Ping
JP
Jiangsu Key Laboratory of Anesthesiology, Xuzhou Medical College, Xuzhou, China.
Zhang
Hong-Xing
HX
Lu
Xian-Fu
XF
Liu
Yue-Peng
YP
Cao
Jun-Li
JL
D000818:Animals; D002070:Butadienes / Q000008:administration & dosage; D036387:Ephrin-B1 / Q000008:administration & dosage* / Q000633:toxicity; D006930:Hyperalgesia / Q000139:chemically induced / Q000201:enzymology / Q000473:pathology; D018836:Inflammation Mediators / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000502:physiology / Q000633:toxicity; D007278:Injections, Spinal; D020935:MAP Kinase Signaling System / Q000187:drug effects / Q000502:physiology*; D008297:Male; D051379:Mice; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D009570:Nitriles / Q000008:administration & dosage; D010146:Pain / Q000139:chemically induced / Q000201:enzymology* / Q000473:pathology; D010147:Pain Measurement / Q000379:methods; D036081:Receptors, Eph Family / Q000502:physiology*
D002070:Butadienes; D036387:Ephrin-B1; D018836:Inflammation Mediators; D009570:Nitriles; C113580:U 0126; D036081:Receptors, Eph Family; D020928:Mitogen-Activated Protein Kinases